Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?

Pulmonary arterial hypertension, a disease largely neglected until a few decades ago, is presently the object of intense studies by several research teams. Despite considerable progress, pulmonary arterial hypertension remains a major clinical problem, because it is not always easy to diagnose, trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Ferraretti, Armando, Monaco, Ilenia, Grazioli, Davide, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174907/
https://www.ncbi.nlm.nih.gov/pubmed/30323613
http://dx.doi.org/10.2147/VHRM.S133921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174907/
https://www.ncbi.nlm.nih.gov/pubmed/30323613
http://dx.doi.org/10.2147/VHRM.S133921

Ejemplares similares